• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Varicella Zoster Immune Globulin (Human)
Trade Name: VARIZIG
Date Designated: 11/07/2006
Orphan Designation: Passive immunization for the treatment of exposed, susceptible individuals who are at risk of complications from varicella
Orphan Designation Status: Designated/Approved
Cangene bioPharma, Inc.
155 Innovation Drive
Winnipeg
Canada

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Varicella Zoster Immune Globulin (Human)
Trade Name: VARIZIG
Marketing Approval Date: 12/20/2012
Approved Labeled Indication: Post exposure prophylaxis of varicella in high risk individuals to reduce the severity of varicella
Exclusivity End Date: 12/20/2019 
Exclusivity Protected Indication* :  

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-